BioTheryX
Aparajita Hoskote Chourasia, PhD, is a highly experienced leader in drug development and biology, currently serving as Senior Vice President at Biotheryx, Inc., where responsibilities include building biology departments, strategizing pipeline programs, and leading the development of innovative drug candidates such as BTX-1188. With a robust background in cancer biology, Aparajita has held positions at Celgene, The University of Chicago, Veridex LLC, Novartis, and Brigham and Women's Hospital, contributing to significant research and development efforts in molecular therapeutics and preclinical studies. Educational credentials include a PhD in Cancer Biology and dual master's degrees in Biochemistry, Molecular Biology, and Translational Science, strengthening a comprehensive expertise in experimental techniques and collaborative mentorship in scientific environments.
This person is not in any offices
BioTheryX
BioTheryX is a clinical-stage biopharmaceutical company that focuses on the development of therapies for hematological malignancies.